• Explore /
  • Poster
  • / Prognostic stratification using the nomogram sarculator and its impact on study results in a randomized controlled trial (RCT) for localized soft tissue sarcomas (STS): A secondary analysis of the EORTC-STBSG 62931.

Prognostic stratification using the nomogram sarculator and its impact on study results in a randomized controlled trial (RCT) for localized soft tissue sarcomas (STS): A secondary analysis of the EORTC-STBSG 62931.

Abstract Poster

Authors

null

Sandro Pasquali

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

Sandro Pasquali , Sara Pizzamiglio , Nathan Touati , Saskia Litiere , Sandrine Marreaud , Bernd Kasper , Hans Gelderblom , Silvia Stacchiotti , Paolo Verderio , Paolo Giovanni Casali , Penella Woll , Alessandro Gronchi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Sarcoma

Track

Sarcoma

Sub Track

Soft Tissue Tumors

Clinical Trial Registration Number

NCT00002641

Citation

J Clin Oncol 36, 2018 (suppl; abstr 11518)

DOI

10.1200/JCO.2018.36.15_suppl.11518

Abstract #

11518

Poster Bd #

263

Abstract Disclosures

Similar Posters

First Author: Sandro Pasquali

Poster

2020 Gastrointestinal Cancers Symposium

Benefit of oxaliplatin in stage III colon cancer according to IDEA risk groups: Analysis of MOSAIC and C-07 trials.

Benefit of oxaliplatin in stage III colon cancer according to IDEA risk groups: Analysis of MOSAIC and C-07 trials.

First Author: Ofer Margalit

First Author: Nicolas Penel

First Author: Richard Hong Hui Quek